BRISBANE LAWYERS TAKE PATENTED ANIMAL PAINKILLER TO THE WORLD

BRISBANE LAWYERS TAKE PATENTED ANIMAL PAINKILLER TO THE WORLD

BRISBANE law firm Bennet & Philip Lawyers has contracted a multi-million-dollar deal to help take a unique Aussie painkiller for animals to the global market.

Bennet & Philip's Michael Bigg and Lance Pollard contracted a deal between Australian company Animal Ethics and UK-based Dechra Pharmaceuticals to launch Animal Ethics' unique pain relief product Tri-Solfen worldwide.

As part of the agreement, Dechra has taken a 33 per cent share of Animal Ethics to obtain the rights to sell Tri-Solfen for use on all animal species overseas.

The deal has the potential of generating $350m per year in international sales.

Pollard says the subject of ethical pain relief for animals is a sensitive international issue, but the Australian company has developed a world leading product.

"People outside the farm industry may not realise it but many farming operations can cause pain to farm animals and the founders of Animal Ethics had an idea to improve animal welfare by reducing pain in animals during routine treatments such as castration, tail docking, debudding and dehorning," says Pollard.

"We are delighted to help take [Tri-Solfen] to a new international level."

Dr Meredith Sheil, a founder of Animal Ethics, developed Tri-Solfen in 2004 for treating lambs after the 'mulesing' process, which is a controversial surgical operation performed on sheep to reduce the flystrike disease.

The painkiller was approved for use on calves last year, and is now used on eight million farm animals a year.

Tri-Solfen now has 35 patents granted across many the world's major animal health markets.

Pollard says the development process is underway to register the product in global markets, with the initial focus being for pigs and cattle in America.

"Globally the market potential is conservatively estimated at around $300 million per year but with the increasing international focus on the ethical treatment of farm animals," says Pollard.

"This sum could be exceeded once multi-species approval is achieved in the big markets."

Brisbane Legal

Get our daily business news

Sign up to our free email news updates.

 
Four time-saving tips for automating your investment portfolio
Partner Content
In today's fast-paced investment landscape, time is a valuable commodity. Fortunately, w...
Etoro
Advertisement

Related Stories

Nick Scali shares reach all-time high following UK expansion plans

Nick Scali shares reach all-time high following UK expansion plans

Nick Scali’s (ASX: NCK) plans to expand into the UK have...

Super Retail Group to face court over allegations of undisclosed exec relationship, bullying

Super Retail Group to face court over allegations of undisclosed exec relationship, bullying

The board of Super Retail Group (ASX: SUL) has announced today that...

Aussie-founded sleep device giant ResMed sees profit lift 29pc

Aussie-founded sleep device giant ResMed sees profit lift 29pc

Shareholders backing Australian-founded, California-based sleep med...

“Difficult decision”: Atlassian co-CEO Scott Farquhar to step down

“Difficult decision”: Atlassian co-CEO Scott Farquhar to step down

After 23 years as co-CEO of Sydney-headquartered software giant Atl...